CORC  > 湖南大学
Target‑specific delivery of oxaliplatin to HER2‑positive gastric cancer cells in vivo using oxaliplatin‑au‑fe3o4‑herceptin nanoparticles
Daren Liu; Xiaowen Li; Changlei Chen; Chao Li; Chuanbiao Zhou; Weidong Zhang; Jiangang Zhao; Jie Fan; Kai Cheng; Li Chen
刊名Oncology Letters
2018
卷号Vol.15 No.5页码:8079-8087
ISSN号1792-1074;1792-1082
URL标识查看原文
公开日期[db:dc_date_available]
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/5461937
专题湖南大学
作者单位Department of General Surgery, Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang 310009, P.R. China, Key Laboratory of Applied Chemistry of Zhejiang, Department of Chemistry, Zhejiang University, Hangzhou, Zhejiang 310009, P.R. China, Molecular Imaging Program, Canary Center for Cancer Early Detection, Department of Radiology and BioX Program, Stanford University, Stanford, CA 94305, USA
推荐引用方式
GB/T 7714
Daren Liu,Xiaowen Li,Changlei Chen,et al. Target‑specific delivery of oxaliplatin to HER2‑positive gastric cancer cells in vivo using oxaliplatin‑au‑fe3o4‑herceptin nanoparticles[J]. Oncology Letters,2018,Vol.15 No.5:8079-8087.
APA Daren Liu.,Xiaowen Li.,Changlei Chen.,Chao Li.,Chuanbiao Zhou.,...&Li Chen.(2018).Target‑specific delivery of oxaliplatin to HER2‑positive gastric cancer cells in vivo using oxaliplatin‑au‑fe3o4‑herceptin nanoparticles.Oncology Letters,Vol.15 No.5,8079-8087.
MLA Daren Liu,et al."Target‑specific delivery of oxaliplatin to HER2‑positive gastric cancer cells in vivo using oxaliplatin‑au‑fe3o4‑herceptin nanoparticles".Oncology Letters Vol.15 No.5(2018):8079-8087.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace